In addition, the activation of p38MAPK and JNK signaling pathway is an important mechanism of I/R liver injury [47, 48], and IL-37 may inhibit the activation of p38MAPK and JNK signaling pathways [3], thereby reducing the release of inflammatory cytokines and improving liver damage. Here, IL37 is linked to injury.